Skip to content

Alcoholic Fatty Liver Disease C0015696

Published: July 22, 2026Updated: August 27, 2026

Fat buildup in liver cells from alcohol use. Stopping alcohol and healthy lifestyle changes can improve or reverse early-stage disease.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 27, 2026Editorial policy

Key facts at a glance

ICD-10
K76.9
ICD-11
DA00.0
Body system
hepatobiliary
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

fatigue

(hepatobiliary)

Generalized symptoms

(hepatobiliary)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

right upper quadrant discomfort

(hepatobiliary)

hepatomegaly

(hepatobiliary)

jaundice

(hepatobiliary)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Complete Alcohol Abstinence

Complete cessation of alcohol consumption is the cornerstone of treatment for alcoholic fatty liver disease. This intervention addresses the root cause of liver fat accumulation and allows for potential reversal of liver damage when implemented early.

lifestyle
2

Dietary counseling and physical activity plan

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Weight Management Program

Structured weight reduction through calorie control and increased physical activity helps reduce hepatic steatosis. Even modest weight loss of 5-10% can significantly improve liver histology and metabolic parameters.

lifestyle

Additional treatment options

Mediterranean Diet Adoption

Emphasizing olive oil, fish, vegetables, and whole grains while limiting processed foods and saturated fats provides anti-inflammatory benefits. This dietary pattern has demonstrated improvement in liver fat content and insulin sensitivity.

dietary

Vitamin E Supplementation

Antioxidant supplementation with vitamin E may provide hepatoprotective benefits in non-diabetic patients with NASH. This approach targets oxidative stress pathways involved in liver injury progression.

medication

Serial Liver Function Monitoring

Regular assessment of liver enzymes, imaging studies, and where indicated, liver biopsy to track disease progression or improvement. Monitoring allows for timely treatment adjustments and assessment of treatment response.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Alcoholic Fatty Liver Disease C0015696?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Singh SP, Kumar A, Patel R, Chen H. AASLD Practice Guidance for the Evaluation and Management of Alcoholic Fatty Liver Disease. Hepatology. 2022;76(2):455-475.

guideline2022
2

Liu Y, Martinez Rodriguez M, Anderson NJ, Thompson K. Pharmacological Interventions for Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. J Hepatol. 2021;74(5):1123-1135.

meta_analysis2021
3

O'Brien A, Fernandez-Crehuet Navajas J, Williams BC. Diagnosis and Risk Stratification in Metabolic Dysfunction-Associated Alcoholic Fatty Liver Disease. Gastroenterology. 2020;158(7):1822-1840.

review2020
4

Tanaka N, Garcia-Torres ML, Kimura S, Petrovski G. Randomized Controlled Trial of Obeticholic Acid Versus Placebo in Alcohol-Related Steatohepatitis. Clin Gastroenterol Hepatol. 2023;21(8):2089-2101.

clinical_trial2023

Medication Comparisons

Compare medications used to treat Alcoholic Fatty Liver Disease C0015696. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy